论文部分内容阅读
目的:探讨肝癌患者淋巴结转移的治疗方法。方法:回顾性分析2000—2001年间东方肝胆外科医院97例合并腹腔淋巴转移肝癌患者的临床资料,根据患者淋巴转移情况的不同,采取原发癌切除后,淋巴结清扫(清扫组)、单纯放疗(放疗组)、清扫+放疗(清扫+放疗组)等不同的治疗方法,并对术后1年及3年存活率进行比较。结果:清扫组、放疗组、清扫+放疗组的1,3年生存率分别为82.1%,68.6%,88.9%和50.0%,23.5%,61.1%,清扫+放疗组明显优于另外两组(P<0.05)。结论:肝癌腹腔淋巴结转移,对转移淋巴结采取清扫、放疗等积极治疗,能延长生存时间,提高生存质量。
Objective: To investigate the treatment of lymph node metastasis in patients with liver cancer. Methods: The clinical data of 97 patients with hepatocellular carcinoma with peritoneal lymphatic metastasis who were treated in Eastern Hepatobiliary Surgery Hospital from 2000 to 2001 were retrospectively analyzed. According to the different status of lymphatic metastasis in patients with primary hepatocellular carcinoma, lymph node dissection, lymph node dissection, radiotherapy alone Radiotherapy group), radiotherapy (radiotherapy + radiotherapy + radiotherapy group) and other different treatment methods, and postoperative 1 year and 3 year survival rates were compared. Results The 1-year and 3-year survival rates of the cleaning group, radiotherapy group and cleaning + radiotherapy group were 82.1%, 68.6%, 88.9% and 50.0%, 23.5% and 61.1% respectively. The clearance and radiotherapy groups were significantly better than the other two groups P <0.05). Conclusion: The metastasis of peritoneal lymph nodes of hepatocellular carcinoma and active treatment of metastatic lymph nodes by sweeping and radiotherapy can prolong the survival time and improve the quality of life.